[Clinical study on treatment with nicergoline in a group of patients with hemiplegia in a post-acute phase].
D000208:Acute Disease; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000368:Aged; D004341:Drug Evaluation; D004873:Ergolines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004877:Ergoloid Mesylates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006429:Hemiplegia / Q000188:drug therapy*; D006801:Humans; D007360:Intelligence / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009048:Motor Skills / Q000187:drug effects; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D004873:Ergolines; D009539:Nicotinic Acids; D004877:Ergoloid Mesylates
Osservazioni cliniche sul trattamento con nicergolina di un gruppo di pazienti emiplegici in fase post-acuta.